Tennr
+5%
est. 2Y upside i
Tennr takes healthcare providers from fax to first visit, faster. Using RaeLM™, the only vision-language model trained to interpret unstructured medical records against complex payor criteria, Tennr helps ensure payor-ready documentation, boost conversions, and cut first‑pass denials.
Rank
#1939
Sector
Healthcare Technology
Est. Liquidity
~5Y
Data Quality
Data: LowTennr's strong moat and large market are overshadowed by missing financial data.
Last updated: July 3, 2026
Strong execution and market expansion could triple valuation to $1.8B, but capped at +200% per stage constraints. Dilution reduces net return to +180%.
Moderate growth leads to ~$907M valuation (50% upside), but diluted by 20% from future rounds, yielding net 30%.
Intense competition from EHR incumbents or slower adoption causes valuation to halve to $302M. After 20% dilution, net downside is -70%.
Preference Stack Risk
highFunding Intensity
2630%Total preferred of $159M over $605M valuation gives 26% overhang, meaning common stock bears significant risk in downside.
Dilution Risk
highGiven capital intensity and limited runway from last raise, another round within 2 years likely, causing ~20% dilution.
Secondary Liquidity
noneNo secondary market trades reported, so liquidity is entirely dependent on exit.
Revenue — 20 roles
- Account Partner · New York City Office
- Associate Account Partner · New York City Office
- Director of Revenue Enablement · New York City Office
- +17 more →
Engineering — 7 roles
- Staff Backend Software Engineer · New York City Office
- Backend Software Engineer · New York City Office
- ML Ops Engineer · New York City Office
- +4 more →
Product — 3 roles
- DME Documentation & Criteria Reviewer · Remote
- Product Manager · New York City Office
- Senior Product Designer · New York City Office
Business Operations — 2 roles
- Controller · New York City Office
- Revenue Operations Manager, Systems & Automation · New York City Office
Last updated: March 10, 2026
Questions to Ask at the Interview
Strategic questions based on Tennr's data — designed to show you've done your homework.
- 1
“How does Tennr plan to displace entrenched EHR workflows given Epic's dominance?”
- 2
“What is the current ARR, growth rate, and path to profitability?”
- 3
“What is the current fully-diluted share count and estimated liquidity horizon for common stock?”
Community
Valuation Sentiment
Our model estimates +5% upside. What do you think?
Anonymous. Do not share material non-public information.
Community Discussion
Comments are reviewed before they appear publicly.
Loading comments...
Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.